![](/images/general/no_picture/200_user.png)
Zhengxi Liu
Examiner (ID: 12144, Phone: (571)270-7509 , Office: P/2611 )
Most Active Art Unit | 2611 |
Art Unit(s) | OPQA, 2611, 2628, 2677 |
Total Applications | 360 |
Issued Applications | 235 |
Pending Applications | 2 |
Abandoned Applications | 123 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18876681
[patent_doc_number] => 20240000050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/335613
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335613 | APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS | Jun 14, 2023 | |
Array
(
[id] => 18657714
[patent_doc_number] => 20230303661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS
[patent_app_type] => utility
[patent_app_number] => 18/328473
[patent_app_country] => US
[patent_app_date] => 2023-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/328473 | SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS | Jun 1, 2023 | Pending |
Array
(
[id] => 18451920
[patent_doc_number] => 20230193199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Methods for Printing Functional Human Neural Tissue
[patent_app_type] => utility
[patent_app_number] => 18/057026
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057026 | Methods for Printing Functional Human Neural Tissue | Nov 17, 2022 | Pending |
Array
(
[id] => 18295793
[patent_doc_number] => 20230105479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/957998
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957998 | OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM | Sep 29, 2022 | Pending |
Array
(
[id] => 18306413
[patent_doc_number] => 20230110313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS
[patent_app_type] => utility
[patent_app_number] => 17/946894
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946894 | SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS | Sep 15, 2022 | Pending |
Array
(
[id] => 18436350
[patent_doc_number] => 20230183644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/931440
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | Sep 11, 2022 | Pending |
Array
(
[id] => 18939852
[patent_doc_number] => 20240034991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => METHOD FOR EFFICIENTLY INDUCING REPROGRAMMING OF HUMAN CELL INTO NEURONAL CELL
[patent_app_type] => utility
[patent_app_number] => 17/874433
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874433 | METHOD FOR EFFICIENTLY INDUCING REPROGRAMMING OF HUMAN CELL INTO NEURONAL CELL | Jul 26, 2022 | Pending |
Array
(
[id] => 18182101
[patent_doc_number] => 20230042830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOSITIONS AND METHODS FOR GENERATION OF RETINAL GANGLION CELLS FROM INDUCIBLE PLURIPOTENT STEM CELLS FOR THE TREATMENT OF PROGRESSIVE OPTIC NEUROPATHIES, INCLUDING GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 17/867335
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867335 | COMPOSITIONS AND METHODS FOR GENERATION OF RETINAL GANGLION CELLS FROM INDUCIBLE PLURIPOTENT STEM CELLS FOR THE TREATMENT OF PROGRESSIVE OPTIC NEUROPATHIES, INCLUDING GLAUCOMA | Jul 17, 2022 | Pending |
Array
(
[id] => 18005281
[patent_doc_number] => 20220364047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => MICROENCAPSULATION-BASED ISOLATION OF HUMAN PLURIPOTENT AND MULTIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/663372
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/663372 | MICROENCAPSULATION-BASED ISOLATION OF HUMAN PLURIPOTENT AND MULTIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME | May 12, 2022 | Pending |
Array
(
[id] => 17958620
[patent_doc_number] => 20220339200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => Differentiation of Olfactory Mucosa Derived Mesenchymal Stem Cells to Schwann Cells for Peripheral Nerve Repair
[patent_app_type] => utility
[patent_app_number] => 17/728956
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728956 | Differentiation of Olfactory Mucosa Derived Mesenchymal Stem Cells to Schwann Cells for Peripheral Nerve Repair | Apr 24, 2022 | Pending |
Array
(
[id] => 17957873
[patent_doc_number] => 20220338453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => ENGINEERED CATFISH AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/723159
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723159
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723159 | ENGINEERED CATFISH AND USES THEREOF | Apr 17, 2022 | Pending |
Array
(
[id] => 17836516
[patent_doc_number] => 20220273821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => RETROVIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/681647
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681647 | RETROVIRAL VECTORS | Feb 24, 2022 | Pending |
Array
(
[id] => 17704917
[patent_doc_number] => 20220204923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CHEMICALLY DEFINED MEDIUM FOR DIFFERENTIATION OF MUSCLE STEM CELLS IN VITRO
[patent_app_type] => utility
[patent_app_number] => 17/582730
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582730 | CHEMICALLY DEFINED MEDIUM FOR DIFFERENTIATION OF MUSCLE STEM CELLS IN VITRO | Jan 23, 2022 | Pending |
Array
(
[id] => 17749959
[patent_doc_number] => 20220228164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => ENGINEERED ANTIGEN PRESENTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/578955
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578955 | ENGINEERED ANTIGEN PRESENTING CELLS | Jan 18, 2022 | Pending |
Array
(
[id] => 17734728
[patent_doc_number] => 20220220187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CHIMERIC RECEPTOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/572618
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572618 | CHIMERIC RECEPTOR THERAPY | Jan 9, 2022 | Pending |
Array
(
[id] => 17732513
[patent_doc_number] => 20220217972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => Methods for cryopreservation of sub-millimeter and millimeter scale biological materials
[patent_app_type] => utility
[patent_app_number] => 17/571802
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571802 | Methods for cryopreservation of sub-millimeter and millimeter scale biological materials | Jan 9, 2022 | Pending |
Array
(
[id] => 19256905
[patent_doc_number] => 12016934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Animal model for SARS-CoV-2-spike induced coagulopathy
[patent_app_type] => utility
[patent_app_number] => 17/552464
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 12552
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552464 | Animal model for SARS-CoV-2-spike induced coagulopathy | Dec 15, 2021 | Issued |
Array
(
[id] => 17657388
[patent_doc_number] => 20220177853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES
[patent_app_type] => utility
[patent_app_number] => 17/545416
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545416 | METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES | Dec 7, 2021 | Pending |
Array
(
[id] => 18124380
[patent_doc_number] => 20230009992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => MESENCHYMAL STEM CELL CULTURE PRODUCT AND METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/545034
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545034 | MESENCHYMAL STEM CELL CULTURE PRODUCT AND METHOD FOR PREPARING THE SAME | Dec 7, 2021 | Pending |
Array
(
[id] => 17561703
[patent_doc_number] => 20220125852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PROTECTION AND REGENERATION OF NEUROLOGICAL FUNCTION BY USING STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/512496
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512496 | PROTECTION AND REGENERATION OF NEUROLOGICAL FUNCTION BY USING STEM CELLS | Oct 26, 2021 | Pending |